483 Chongqing Daxin Pharmaceutical Jan 2015

483 Chongqing Daxin Pharmaceutical Jan 2015

Jeffrey Meng FDA$119.00 - Available Now

FDA investigators audited the Chongqing Daxin Pharmaceutical - Chongqing, China facility and issued inspectional observations (via FDA 483) on 29 Jan 2015.

Product details

  • Category: Human Drugs
  • Inspection end: 29 Jan 2015
  • Location: Chongqing, China
  • FEI: 3000291692
Add To Cart